VISHWA JEET AMATYA

Last Updated :2024/05/23

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medicine), Associate Professor or Lecturer
Web Site
https://pathology.hiroshima-u.ac.jp/index-en.html
E-mail
amatyahiroshima-u.ac.jp
Other Contact Details
Department of Pathology Hiroshima University Graduate School of Biomedical & Health Sciences 1-2-3 Kasumi, Minami-ku, Hiroshima JAPAN 734-8551, Japan
TEL : (+81)82-257-5152 FAX : (+81)82-257-5154
Self-introduction
Working in Department of Pathology, Hiroshima University Graduate School of Biomedical & Health Sciences. My research interest is to understand the diagnostic approach and its biology of malignant mesothelioma.

Basic Information

Major Professional Backgrounds

  • 2019/04/01, Hiroshima University Graduate School of Biomedical & Health Sciences, Department of Pathology, Lecturer
  • 2012/10/01, 2019/03/31, Hiroshima University Institute of Biomedical & Health Sciences, Department of Pathology, Lecturer
  • 2007/04/01, 2012/09/31, Hiroshima University Graduate School of Biomedical Sciences, Department of Pathology, Assistant Professor
  • 2005/05/01, 2007/03/31, Hiroshima University Graduate School of Biomedical Sciences, Department of Pathology, Research Assistant
  • 2003/11/01, 2005/04/30, International Agency for Research on Cancer, WHO, LYON, Molecular Pathology, Post Doctoral Fellow
  • 2003/08/01, 2003/10/30, Nepal Medical College, Kathmandu, NEPAL, Department of Pathology, Lecturer

Educational Backgrounds

  • Hiroshima University, Graduate School of Medicine, PhD (Medicine), Japan, 1999/04, 2003/03
  • Hiroshima University, Graduate School of Medicine, Foreign Researcher [Neuropathology], Japan, 1997/10, 1999/03
  • Tribhuvan University, Institute of Medicine, MD [Pathology], Nepal, 1995/04, 1997/09
  • Gorakhpur University, BRD Medical College, MBBS, INDIA, 1987/09, 1992/08

Academic Degrees

  • PhD [Medicine], Hiroshima University
  • MBBS, BRD Medical College, Gorakhpur University, INDIA

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Basic medicine;Human pathology
  • Medicine,dentistry, and pharmacy;Basic medicine;Experimental pathology

Research Keywords

  • Mesothelioma
  • Lung Cancer
  • Asbestos Related Lung Cancer
  • Comprehensive Gene Expression Analysis
  • MiRNA Expression & Functional Analysis
  • Brain Tumor Pathology

Affiliated Academic Societies

  • The International Association for the Study of Lung Cancer (IASLC), 2017
    Related URL
  • The Japan Lung Cancer Society, 2005
    Related URL
  • Japan Asbestos・Mesothelioma Study Group, 2005
  • The Japan Society of Brain Tumor Pathology, 2001
    Related URL
  • The Japanese Cancer Association, 2000
    Related URL
  • The Japanese Society of Pathology, 1999
    Related URL
  • Nepal Medical Association, 1992
    Related URL

Educational Activity

Course in Charge

  1. 2024, Graduate Education (Master's Program) , Second Semester, Research
  2. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar
  3. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar
  4. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Research
  5. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Research
  6. 2024, Graduate Education (Master's Program) , Second Semester, Pathologic Basis of Diseases
  7. 2024, Graduate Education (Master's Program) , 1Term, Methods in Biomedical Sciences A
  8. 2024, Graduate Education (Doctoral Program) , 3Term, Creation and Development of Biomedical Sciences
  9. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Pathology
  10. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Pathology
  11. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Pathology
  12. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Pathology
  13. 2024, Liberal Arts Education Program1, 2Term, Peace Messages from "Kasumi Campus"
  14. 2024, Undergraduate Education, Second Semester, Clinical Pathology
  15. 2024, Undergraduate Education, Intensive, Practice of Medicine I
  16. 2024, Undergraduate Education, First Semester, General Pathology
  17. 2024, Undergraduate Education, First Semester, Pathology
  18. 2024, Undergraduate Education, First Semester, Pathology
  19. 2024, Undergraduate Education, Intensive, Pathology
  20. 2024, Undergraduate Education, First Semester, Outline of Pathology
  21. 2024, Graduate Education (Master's Program) , First Semester, Seminar
  22. 2024, Graduate Education (Master's Program) , Second Semester, Seminar
  23. 2024, Graduate Education (Master's Program) , First Semester, Research

Research Activities

Academic Papers

  1. SPARC Is a Novel Positive Immunohistochemical Marker of Epithelioid Mesothelioma to Differentiate It From Lung Adenocarcinoma and/or Squamous Cell Carcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 48(2), 140-149, 20240201
    Link to Paper Search Results by DOI
  2. Long Non-coding RNA LINC00152 Requires EZH2 to Promote Mesothelioma Cell Proliferation, Migration, and Invasion, ANTICANCER RESEARCH, 43(12), 5367-5375, 20231201
    Link to Paper Search Results by DOI
  3. Musashi-1 Is a Novel Immunohistochemical Marker of Neuroendocrine Carcinoma of the Lung, CANCERS, 15(23), 1-11, 20231201
    Link to Paper Search Results by DOI
  4. Differences in invasiveness and recurrence rate among nonfunctioning pituitary neuroendocrine tumors depending on tumor subtype, NEUROSURGICAL REVIEW, 46(317), 1-9, 20231101
    Link to Paper Search Results by DOI
  5. Residual diffusion-weighted imaging hyperintense signal in primary central nervous system lymphoma can predict early recurrence, JOURNAL OF NEURO-ONCOLOGY, 165(1), 171-179, 20231001
    Link to Paper Search Results by DOI
  6. Characteristics and therapeutic strategies of brain and cranial radiation-induced sarcoma: analysis of 165 cases from our case experience and comprehensive review, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 53(10), 905-911, 20231001
    Link to Paper Search Results by DOI
  7. FOXM1 Promotes Mesothelioma Cell Migration and Invasion via Activation of SMAD Signaling, ANTICANCER RESEARCH, 43(9), 3961-3968, 20230901
    Link to Paper Search Results by DOI
  8. miR-142-3p Suppresses Invasion and Adhesion of Mesothelioma Cells by Downregulating ITGAV, PATHOBIOLOGY, 90(4), 270-280, 20230801
    Link to Paper Search Results by DOI
  9. Optic tract edema in craniopharyngioma as a predictor of BRAFV600E mutation presence, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 53(5), 378-385, 20230429
    Link to Paper Search Results by DOI
  10. Characteristics and therapeutic strategies of radiation-induced glioma: case series and comprehensive literature review, JOURNAL OF NEURO-ONCOLOGY, 159(3), 531-538, 20220901
    Link to Paper Search Results by DOI
  11. Downregulation of FTL decreases proliferation of malignant mesothelioma cells by inducing G(1) cell cycle arrest, ONCOLOGY LETTERS, 23(6), 174, 20220601
    Link to Paper Search Results by DOI
  12. Isolated Neurohypophysial Sarcoidosis Involving the Cavernous Sinus Mimicking a Malignant Tumor, NMC CASE REPORT JOURNAL, 9(1), 31-35, 202203
    Link to Paper Search Results by DOI
  13. Diffusion-weighted imaging-gadolinium enhancement mismatch sign in diffuse midline glioma, EUROPEAN JOURNAL OF RADIOLOGY, 147, 202202
    Link to Paper Search Results by DOI
  14. Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1, ONCOLOGY REPORTS, 47(2), 27, 202202
    Link to Paper Search Results by DOI
  15. Intratumoral Hemorrhage After Endoscopic Third Ventriculostomy for Obstructive Hydrocephalus Caused by Brain Tumors, WORLD NEUROSURGERY, 158, E256-E264, 202202
    Link to Paper Search Results by DOI
  16. Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor, DIAGNOSTICS (BASEL), 12(2), 316-(1-12), 202201
    Link to Paper Search Results by DOI
  17. Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Promotes Cell Proliferation of Malignant Mesothelioma Cells by Downregulating p27Kip1., FRONTIERS IN ONCOLOGY, 11, 795467-(1-10), 202201
    Link to Paper Search Results by DOI
  18. Metachronous Double Pituitary Adenoma with Altered Transcriptional Factor Profile: A Case Report and Literature Review, NMC CASE REPORT JOURNAL, 8(1), 657-663, 202110
    Link to Paper Search Results by DOI
  19. Detecting non-germinomatous germ cell tumor component by arterial spin labeling perfusion-weighted MR imaging in central nervous system germ cell tumor, EUROPEAN JOURNAL OF RADIOLOGY, 136, 202103
    Link to Paper Search Results by DOI
  20. Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung, TRANSLATIONAL LUNG CANCER RESEARCH, 10(2), 766-+, 202102
    Link to Paper Search Results by DOI
  21. Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress, PATHOLOGY INTERNATIONAL, 70(12), 943-952, 202012
    Link to Paper Search Results by DOI
  22. Radiological and Immunostaining Characteristics of H3.3 G34R-Mutant Glioma: A Report of 3 Cases and Review of the Literature, PEDIATRIC NEUROSURGERY, 55(5), 319-325, 202012
    Link to Paper Search Results by DOI
  23. SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma from Lung Adenocarcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 44(9), 1259-1265, 202009
    Link to Paper Search Results by DOI
  24. Radiology Profile as a Potential Instrument to Differentiate Between Posterior Fossa Ependymoma (PF-EPN) Group A and B, WORLD NEUROSURGERY, 140, E320-E327, 202008
    Link to Paper Search Results by DOI
  25. Advantage of high b value diffusion -weighted imaging for differentiation of common pediatric brain tumors in posterior fossa, EUROPEAN JOURNAL OF RADIOLOGY, 128(108983), 202007
    Link to Paper Search Results by DOI
  26. Inhibition of miR-18a-3p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin, ONCOLOGY LETTERS, 19(6), 4161-4168, 202006
    Link to Paper Search Results by DOI
  27. T2-FLAIR mismatch sign in dysembryoplasticneuroepithelial tumor, EUROPEAN JOURNAL OF RADIOLOGY, 126, 202005
    Link to Paper Search Results by DOI
  28. Primary and Recurrent Growing Teratoma Syndrome in Central Nervous System Nongerminomatous Germ Cell Tumors: Case Series and Review of the Literature, WORLD NEUROSURGERY, 134, E360-E371, 202002
    Link to Paper Search Results by DOI
  29. Utility of dual-energy CT for predicting the vascularity of meningiomas, EUROPEAN JOURNAL OF RADIOLOGY, 123, 202002
    Link to Paper Search Results by DOI
  30. Effect of bevacizumab against cystic components of brain tumors, CANCER MEDICINE, 8(15), 6519-6527, 201911
    Link to Paper Search Results by DOI
  31. Retrospective immunohistological study of autopsied lungs in patients with acute exacerbation of interstitial pneumonia managed with extracorporeal membrane oxygenation, JOURNAL OF THORACIC DISEASE, 11(11), 4436-4443, 201911
    Link to Paper Search Results by DOI
  32. Immunostaining of Increased Expression of Enhancer of Zeste Homolog 2 (EZH2) in Diffuse Midline Glioma H3K27M-Mutant Patients with Poor Survival., PATHOBIOLOGY, 86(2-3), 152-161, 201905
    Link to Paper Search Results by DOI
  33. Metastatic Malignant Lymphoma Mimicking Cerebral Toxoplasmosis with the "Target Sign", INTERNAL MEDICINE, 58(8), 1157-1162, 201904
    Link to Paper Search Results by DOI
  34. Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma., HISTOPATHOLOGY, 74(4), 545-554, 201903
    Link to Paper Search Results by DOI
  35. Reply to 'MUC4 staining in sarcomatoid carcinomas' by Berg et al., MODERN PATHOLOGY, 32(1), 158-158, 201901
    Link to Paper Search Results by DOI
  36. Perfusion Computed Tomography Parameters Are Useful for Differentiating Glioblastoma, Lymphoma, and Metastasis, WORLD NEUROSURGERY, 119, E890-E897, 201811
    Link to Paper Search Results by DOI
  37. miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma, FRONTIERS IN ONCOLOGY, 8(446), 1-9, 201810
    Link to Paper Search Results by DOI
  38. Astroblastoma: a distinct tumor entity characterized by alterations of the X chromosome and MN1 rearrangement, BRAIN PATHOLOGY, 28(5), 684-694, 201809
    Link to Paper Search Results by DOI
  39. Concurrent Schwannoma and Meningioma Arising in the Same Spinal Level: A Report of Two Cases, NMC CASE REPORT JOURNAL, 5(4), 105-109, 201809
    Link to Paper Search Results by DOI
  40. Improved differentiation between high- and low-grade gliomas by combining dual-energy CT analysis and perfusion CT, MEDICINE (Baltimore), 97(32), e11670, 201808
    Link to Paper Search Results by DOI
  41. Coexistence of gastrointestinal stromal tumor and leiomyosarcoma of the stomach presenting as a collision tumor: A case report and review of literature, PATHOLOGY INTERNATIONAL, 68(5), 313-317, 201805
    Link to Paper Search Results by DOI
  42. Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma, MODERN PATHOLOGY, 31(5), 809-815, 201805
    Link to Paper Search Results by DOI
  43. Proton Magnetic Resonance Spectroscopy Detection of High Lipid Levels and Low Apparent Diffusion Coefficient Is Characteristic of Germinomas, WORLD NEUROSURGERY, 112, E84-E94, 201804
    Link to Paper Search Results by DOI
  44. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator, JOURNAL OF NEUROSURGERY, 128(3), 667-678, 201803
    Link to Paper Search Results by DOI
  45. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide., JOURNAL OF NEUROSURGERY, 128(3), 679-684, 201803
    Link to Paper Search Results by DOI
  46. Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia, ONCOLOGY LETTERS, 15(3), 3540-3547, 201803
    Link to Paper Search Results by DOI
  47. MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung, SCIENTIFIC REPORTS, 8(134), 1-8, 201801
    Link to Paper Search Results by DOI
  48. RELA fusion-positive anaplastic ependymoma: molecular characterization and advanced MR imaging, BRAIN TUMOR PATHOLOGY, 35(1), 41-45, 201801
    Link to Paper Search Results by DOI
  49. Role for loss of nuclear PTEN in a harbinger of brain metastases, JOURNAL OF CLINICAL NEUROSCIENCE, 44, 148-154, 201710
    Link to Paper Search Results by DOI
  50. Diffuse leptomeningeal glioneuronal tumor (DLGNT) mimicking Whipple's disease: a case report and literature review, CHILDS NERVOUS SYSTEM, 33(8), 1411-1414, 201708
    Link to Paper Search Results by DOI
  51. Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 41(8), 1045-1052, 201708
    Link to Paper Search Results by DOI
  52. Sellar Atypical Teratoid/Rhabdoid Tumor (AT/RT): A Clinicopathologically and Genetically Distinct Variant of AT/RT, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 41(7), 932-940, 201707
    Link to Paper Search Results by DOI
  53. ★, MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma, MODERN PATHOLOGY, 30(5), 672-681, 201705
    Link to Paper Search Results by DOI
  54. PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells, INTERNATIONAL JOURNAL OF ONCOLOGY, 50(3), 1029-1034, 201703
    Link to Paper Search Results by DOI
  55. Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway: Immunohistochemical Study of Multicentric Glioma, PATHOBIOLOGY, 84(2), 99-107, 201702
    Link to Paper Search Results by DOI
  56. ★, Utility and pitfall of Immunohistochemistry in the Differential Diagnosis between Epithelioid Mesothelioma and Poorly Differentiated Lung Squamous Cell Carcinoma., HISTOPATHOLOGY, 70(3), 375-384, 201702
    Link to Paper Search Results by DOI
  57. Solitary Langerhans cell histiocytosis located in the neurohypophysis with a positive titer HCG-beta in the cerebrospinal fluid, CHILDS NERVOUS SYSTEM, 32(5), 901-904, 201605
    Link to Paper Search Results by DOI
  58. Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma, INTERNATIONAL JOURNAL OF ONCOLOGY, 48(4), 1599-1607, 201604
    Link to Paper Search Results by DOI
  59. Benign fibrous histiocytoma arising at the temporal bone of an infant - case report and review of the literature., CHILDS NERVOUS SYSTEM, 32(1), 189-193, 201601
    Link to Paper Search Results by DOI
  60. Use of Anti-Noxa Antibody for Differential Diagnosis between Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia., PATHOBIOLOGY, 83(1), 33-40, 201601
    Link to Paper Search Results by DOI
  61. Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma., JOURNAL OF NEUROSURGERY, 122(6), 1370-1379, 201506
    Link to Paper Search Results by DOI
  62. Desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia., INTERNATIONAL CANCER CONFERENCE JOURNAL, 2(3), 178-182, 201307
    Link to Paper Search Results by DOI
  63. A case of malignant fibrous histiocytoma of the petrous bone present-ing with facial nerve palsy, JAPANESE JOURNAL OF NEUROSURGERY, 22(4), 306-312, 201304
  64. A case of papillary glioneuronal tumor, JAPANESE JOURNAL OF NEUROSURGERY, 22(11), 860-865, 201301
  65. CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma., ONCOLOGY REPORTS, 29(1), 21-28, 201301
    Link to Paper Search Results by DOI
  66. CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma, CLINICAL CANCER RESEARCH, 18(5), 1447-1456, 201203
    Link to Paper Search Results by DOI
  67. Lymphomas and glioblastomas: Differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3 T, EUROPEAN JOURNAL OF RADIOLOGY, 81(2), 339-344, 201202
    Link to Paper Search Results by DOI
  68. Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas, EUROPEAN JOURNAL OF RADIOLOGY, 80(2), 412-417, 201111
    Link to Paper Search Results by DOI
  69. Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines, ONCOLOGY REPORTS, 26(6), 1369-1375, 201109
    Link to Paper Search Results by DOI
  70. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma., ONCOLOGY REPORTS, 24(2), 423-431, 201008
    Link to Paper Search Results by DOI
  71. Evaluation of Apoptosis and Immunohistochemical Expression of the Apoptosis-related Proteins in Mesothelioma, HIROSHIMA JOURNAL OF MEDICAL SCIENCES, 59(2), 27-33, 201006
    Link to Paper Search Results by DOI
  72. Myogenic antigen expression is useful for differentiation between epithelioid mesothelioma and non-neoplastic mesothelial cells., HISTOPATHOLOGY, 56(7), 969-974, 201006
    Link to Paper Search Results by DOI
  73. Trigeminal neuropathy from perineural spread of an amyloidoma detected by blink reflex and thin-slice magnetic resonance imaging, MUSCLE & NERVE, 41(6), 875-878, 201006
    Link to Paper Search Results by DOI
  74. Glioblastoma treated with postoperative radio-chemotherapy: Prognostic value of apparent diffusion coefficient at MR imaging, EUROPEAN JOURNAL OF RADIOLOGY, 73(3), 532-537, 201003
    Link to Paper Search Results by DOI
  75. Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the diagnosis of sellar and parasellar lesions, EUROPEAN JOURNAL OF RADIOLOGY, 74(3), 420-427, 201003
    Link to Paper Search Results by DOI
  76. Accuracy of pathological diagnosis of mesothelioma cases in Japan: Clinicopathological analysis of 382 cases, LUNG CANCER, 66(2), 191-197, 200911
    Link to Paper Search Results by DOI
  77. Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma, HISTOPATHOLOGY, 55(1), 10-19, 200907
    Link to Paper Search Results by DOI
  78. Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma, HISTOPATHOLOGY, 54(6), 667-676, 200905
    Link to Paper Search Results by DOI
  79. Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: Comparative study with 11 pilocytic astrocytomas, PATHOLOGY INTERNATIONAL, 59(2), 80-85, 200902
    Link to Paper Search Results by DOI
  80. Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone, JOURNAL OF NEUROSURGERY, 110(2), 369-373, 200902
    Link to Paper Search Results by DOI
  81. A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases, AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 130(5), 771-779, 200811
    Link to Paper Search Results by DOI
  82. Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer., CANCER SCIENCE, 99(8), 1570-1577, 200808
    Link to Paper Search Results by DOI
  83. Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry, PATHOLOGY INTERNATIONAL, 58(2), 75-83, 200802
    Link to Paper Search Results by DOI
  84. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma, PATHOLOGY INTERNATIONAL, 57(4), 190-199, 200704
    Link to Paper Search Results by DOI
  85. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast, PATHOLOGY INTERNATIONAL, 56(5), 256-261, 200605
    Link to Paper Search Results by DOI
  86. TP53 promoter methylation in human gliomas, ACTA NEUROPATHOLOGICA, 110(2), 178-184, 200508
    Link to Paper Search Results by DOI
  87. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma, PATHOLOGY INTERNATIONAL, 55(1), 14-18, 200501
    Link to Paper Search Results by DOI
  88. Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation, PATHOLOGY INTERNATIONAL, 54(10), 803-809, 200410
    Link to Paper Search Results by DOI
  89. Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung, PATHOLOGY INTERNATIONAL, 54(7), 486-489, 200407
    Link to Paper Search Results by DOI
  90. Meningioma in mature cystic teratoma of the ovary, PATHOLOGY INTERNATIONAL, 54(7), 543-548, 200407
    Link to Paper Search Results by DOI
  91. ★, Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation, MODERN PATHOLOGY, 17(6), 705-710, 200406
    Link to Paper Search Results by DOI
  92. Study of methylation status of p14/ARF gene in benign, atypical, and anaplastic meningiomas by methylation specific PCR, International Congress Series, 1259(C), 13-14, 200402
  93. Myxopapillary ependymoma with anaplastic features, PATHOLOGY INTERNATIONAL, 53(10), 700-703, 200310
    Link to Paper Search Results by DOI
  94. Case of clear cell ependymoma of medulla oblongata: Clinicopathological and immunohistochemical study with literature review, PATHOLOGY INTERNATIONAL, 53(5), 297-302, 200305
    Link to Paper Search Results by DOI
  95. Co-existent carcinosarcoma and adenoid basal carcinoma of the uterine cervix and correlation with human papillomavirus infection, INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 21(2), 186-190, 200204
    Link to Paper Search Results by DOI
  96. Meningioangiomatosis occurring in a young male without neurofibromatosis - With special reference to its histogenesis and loss of heterozygosity in the NF2 gene region, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 26(1), 125-129, 200201
    Link to Paper Search Results by DOI
  97. Heterogeneous genetic alterations in ovarian mucinous tumors: Application and usefulness of laser capture microdissection, HUMAN PATHOLOGY, 32(11), 1203-1208, 200111
    Link to Paper Search Results by DOI
  98. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21(WAF1), and p27(KIP1) expression in benign, atypical, and anaplastic meningiomas, HUMAN PATHOLOGY, 32(9), 970-975, 200109
    Link to Paper Search Results by DOI
  99. Dysplastic glioneuronal lesion arising in the cerebellum: a clinicopathological, immunohistochemical and ultrastructural study, CLINICAL NEUROPATHOLOGY, 20(2), 73-79, 200103
  100. Idiopathic granulomatous meningoencephalitis presenting as an intracranial tumor, PATHOLOGY INTERNATIONAL, 49(12), 1084-1088, 199912
    Link to Paper Search Results by DOI

Invited Lecture, Oral Presentation, Poster Presentation

  1. O1-10 Utility of 5-hmC, EZH2, and c-Met in differential diagnosis of mesothelioma and reactive mesothelium, The 113th Annual Meeting of the Japanese Society of Pathology, 2024/03/28, Without Invitation, Japanese, The Japanese Society of Pathology, Nagoya, experimental
  2. P-162 A case of sarcomatoid mesothelioma with immunohistochemically positive for CD31, The 113th Annual Meeting of the Japanese Society of Pathology, 2024/03/28, Without Invitation, Japanese, The Japanese Society of Pathology, Nagoya, experimental
  3. O1-63 miR-142-3p Suppresses Invasion and Adhesion of Mesothelioma Cells by Downregulating ITGAV, The 112th Annual Meeting of the Japanese Society of Pathology, 2023/04/13, Without Invitation, Japanese, The Japanese Society of Pathology, Shimonoseki, Japan, experimental
  4. P-227 A case of pulmonary lymphomatoid granulomatosis, The 112th Annual Meeting of the Japanese Society of Pathology, 2023/04/13, Without Invitation, Japanese, The Japanese Society of Pathology, Shimonoseki, Japan, experimental
  5. O1-61 SPARC, a novel marker for differentiating epithelioid mesothelioma from non-small cell lung cancer, The 112th Annual Meeting of the Japanese Society of Pathology, 2023/04/13, Without Invitation, Japanese, The Japanese Society of Pathology, Shimonoseki, Japan, experimental
  6. O1-62 SPARC, a novel marker for differentiating epithelioid mesothelioma from non-small cell lung cancer, The 112th Annual Meeting of the Japanese Society of Pathology, 2023/04/13, Without Invitation, Japanese, The Japanese Society of Pathology, Shimonoseki, Japan, experimental
  7. O2-48 Knockdown of PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1, AMATYA VISHWA JEET, The 111th Annual Meeting of the Japanese Society of Pathology, 2022/04/14, Without Invitation, English, The Japanese Society of Pathology, Kobe, Japan, experimental
  8. O3-02 Gene expression microarray analysis of asbestos-related lung cancer in Japanese patients, AMATYA VISHWAJEET, Kishitani Kei, Takeshima Yukio, The 110th Annual Meeting of the Japanese Society of Pathology, 2021/04/22, Without Invitation, English, The Japanese Society of Pathology, Tokyo, experimental
  9. Alterations of 2p16, 9q33.1 and 19p13 in asbestos-related lung cancer in Japanese patients, AMATYA VISHWA JEET, the 109th Annual Meeting of the Japanese Society of Pathology, 2020/07/01, Without Invitation, English, the Japanese Society of Pathology, Fukuoka, published
  10. Musashi-1 is novel immunohistochemical marker of neuroendorine carcinoma of lung, 2019/12/06, Without Invitation, English, experimental
  11. Musashi-1 is a novel immunohistochemical marker of small cell carcinoma of lung, 2019/05/09, Without Invitation, English, experimental
  12. CM2-3: Exploration of the novel immunohistochemical markers of epithelioid mesothelioma and lung adenocarcinoma, Vishwa Jeet Amatya, Kei Kushitani, Takeshima Yukio, The 64th Autumn Annual Meeting of The Japanese Society of Pathology, 2018/11/23, With Invitation, Japanese, published
  13. p35: miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma, Rui Suzuki, Vishwa Jeet Amatya, Kei Kushitani, Kai Yuichiro, Kambara Takahiro, Yukio Takeshima, The 64th Autumn Annual Meeting of The Japanese Society of Pathology, 2018/11/22, Without Invitation, Japanese, published
  14. HGG-21. IMAGING AND IMMUNOHISTOCHEMICAL CHARACTERISTICS OF H3 G34R-MUTANT GLIOMAS -A REPORT OF TWO CASES, Shumpei Onishi, Vega Karlowee, Yoshiko Nakano, Manish Kolakshyapati, Takeshi Takayasu, Motoki Takano, Vishwa Jeet Amatya, Yukio Takeshima, Koichi Ichimura, Kazuhiko Sugiyama, Kaoru Kurisu, Fumiyuki Yamasaki, The 18th International Symposium on Pediatric Neuro-Oncology, 2018/06/30, Without Invitation, English, Society for Neuro-Oncology, Colorado, USA, published
  15. 3-I-16: Glypican-1 is the positive marker to differentiate epithelioid mesothelioma from lung adenocarcinoma, Amatya Vishwa Jeet, Suzuki R, Kai Y, Kushitani K, Miyata Y, Okada M, Takeshima Y, The 107th Annual Meeting of the Japanese Society of Pathology, 2018/06/23, Without Invitation, English, published
  16. 1-D-15 Utility of Annexin-8 Immunostaining for Differential Diagnosis of Mesothelioma and Lung Cancer, Kushitani K, Amatya Vishwa Jeet, Suzuki R, Kai Y, Takeshima Y., The 107th Annual Meeting of the Japanese Society of Pathology, 2018/06/21, Without Invitation, Japanese, Sapporo, Japan, published
  17. NIMG-20. ANALYSIS OF PERFUSION CT PARAMETERS FOR DIFFERENTIATING AMONG GLIOBLASTOMA, PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA AND BRAIN METASTASIS, Shumpei Onishi, Yoshinori Kajiwara, Takeshi Takayasu, Manish Kolakshyapati, Minoru Ishifuro, Vishwa Jeet Amatya, Yukio Takeshima, Kazuhiko Sugiyama, Kaoru Kurisu, Fumiyuki Yamasaki, 2017/11/06, Without Invitation, English, Society for Neuro-Oncology, San Francisco, California, published
  18. Diagnostic utility of MUC4 expression to differentiate epithelioid mesothelioma from lung adenocarcinoma and squamous cell carcinoma, Amatya Vishwa Jeet, Mamas AS, Kushitani K, Kai Y, Miyata Y, Okada M, and Takeshima Y., 18th World Conference on Lung Cancer, 2017/10/15, Without Invitation, English, The International Association for the Study of Lung Cancer (IASLC), Yokohama, Japan, experimental
  19. Identification of DAB2 and Intelection-1 as novel positive immunohistochemical markers of epithelioid mesothelioma, Kuraoka M., AMATYA VISHWA JEET, Kushitani K., Mawas A.S., Miyata Y., Okada M., Kishimoto T., Inai K., Nishisaka T., Sueda T., and Takeshima Y., 18th World Conference on Lung Cancer, 2017/10/15, Without Invitation, English, The International Association for the Study of Lung Cancer (IASLC), Yokohama, Japan, published
  20. Usefulness of immunohistochemistry in the differential diagnosis of epithelioid mesothelioma and lung squamous cell carcinoma, Kushitani K., AMATYA VISHWA JEET, Okada Y., Katayama Y., Mawas A.S., Miyata Y., Okada M., Inai K., Kishimoto T, and Takeshima Y., 18th World Conference on Lung Cancer, 2017/10/15, Without Invitation, English, The International Association for the Study of Lung Cancer (IASLC), Yokohama, Japan, preprint
  21. Sellar atypical teratoid/rhabdoid tumor (AT/RT): A clinicopathologically and genetically distinct variant of AT/RT, Nakata S.; Nobusawa T.; Hirose T; Ito S.; Inoshita N.; Ichi S.; AMATYA VISHWA JEET; Sugiyama K.; Sonoda Y.; Haga H.; Hirato J.; Nakazato Y.; Yokoo H., 3rd Congress of the European Academy of Neurology, 2017/06/24, Without Invitation, English, European Academy of Neurology and the Netherlands Society of Neurology, Amsterdam
  22. Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway, Karlowee V, Yamasaki F, Amatya Vishwa Jeet, Hirano H, Takayasu T, Nosaka R, Takeshima Y, Sugiyama K, Arita K, Kurisu K., The 35th Annual Meeting of the Japan Society of Brain Tumor Pathology, 2017/05/19, Without Invitation, English, published
  23. A case of small cell mesothelioma of the pleura, Mayumi Kaneko; Hiroo Matsuura; Hiromi Egawa; Hiroki Kitagawa; Takuhiro Ikeda; Hidenori Mukaida; Vishwa Jeet Amatya; Yukio Takeshima, The 106th Annual Meeting of the Japanese Society of Pathology, 2017/04/27, Without Invitation, Japanese, experimental
  24. PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells, Suzuki R, Mawas AS, Miyahara S, Ohoka I, Amatya Vishwa Jeet, Kushitani K, Takeshima Y, The 106th Annual Meeting of the Japanese Society of Pathology, 2017/04/27, Without Invitation, Japanese, Tokyo, Japan, experimental
  25. Utility of Intelectin-1 and DAB2 immunostain in distinguishing mesothelioma from lung adenocarcinoma, Kushitani K, Amatya Vishwa Jeet, Miyahara S, Ohoka I, Suzuki R, Mawas AS, Takeshima Y, The 106th Annual Meeting of the Japanese Society of Pathology, 2017/04/27, Without Invitation, Japanese, experimental
  26. Differential diagnosis between mesothelioma and reactive mesothelium using immunohistochemistry, Ohoka I, Kushitani K, Amatya Viswa Jeet, Mawas AS, Suzuki R, Miyahara S, Takeshima Y, The 106th Annual Meeting of the Japanese Society of Pathology, 2017/04/27, Without Invitation, Japanese, Tokyo, Japan, experimental
  27. MUC4, immunohistochemical marker to differentiate lung adenocarcinoma from epithelioid mesothelioma, Amatya Vishwa Jeet, Kushitani K, Suzuki R, Mawas AS, Takeshima Y, The 106th Annual Meeting of the Japanese Society of Pathology, 2017/04/27, Without Invitation, English, Tokyo, Japan, experimental
  28. Protein expression profile in acute exacerbation of interstitial pneumonia supported on V-V ECMO, Kida Y, Ohshima S, Kyo M, Amatya Vishwa Jeet, Takeshima Y, Shime N, Society of Critical Care Medicine's 46th Critical Care Congress, 2017/01/21, Without Invitation, English, Honolulu, Hawaii, USA, experimental
  29. MUC4 is novel markers to differentiate sarcomatoid mesothelioma from sarcomatoid carcinoma of lung., Amatya Vishwa Jeet, Mawas AS, 櫛谷桂, 武島幸男, The 57th Annual Meeting of Japanese Lung Cancer Society, 2016/12/19, Without Invitation, English, experimental
  30. Clinical implication of High B-value DWI for preoperative differentiation of glioblastoma from itsdifferentials, Kolakshyapati M, Adhikari RB, Takayasu T, Nosaka R, Amatya,Vishwa Jeet, Takeshima Y, Akiyama Y, Sugiyama K, Kurisu K, Yamasaki F, The 21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology, 2016/11/17, Without Invitation, English, Arizona, USA, experimental
  31. Immunohistochemical study of multicentric glioma, Vega Karlowee, Amatya Vishwa Jeet，平野宏文，高安武志，野坂亮，Kolakshyapati M，吉廣正子，武島幸男，杉山一彦，有田和徳，栗栖薫，山崎文之, 第30回中国四国脳腫瘍研究会, 2016/09/22, Without Invitation, English, experimental
  32. Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma, Amatya Vishwa Jeet, Mawas AS, Suzuki R, Kushitani K, Mohi El-Din MM, Takeshima Y., GAP (Global Academic Program) related Meeting Between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, English, Hiroshima, Japan, experimental
  33. Gene expression microarray analysis of sarcomatoid mesothelioma and sarcomatoid carcinoma of lung, Amatya Vishwa Jeet, 繰田智之，髙木祐基, Mawas AS，櫛谷　桂，武島幸男, The 105th Annual Meeting of the Japanese Society of Pathology, 2016/05/12, Without Invitation, English, Sendai, Japan, experimental
  34. Functional analysis of PIM-1 expressions in mesothelioma cell lines, Mawas AS, Amatya Vishwa Jeet，櫛谷　桂，武島幸男, The 105th Annual Meeting of the Japanese Society of Pathology, 2016/05/12, Without Invitation, English, Sendai, Japan, experimental
  35. MiR-1, MiR-214 reduces cell proliferation and invasion in mesothelioma cells, AMATYA VISHWA JEET, Mawas Amany Sayed, Kei Kushitani, Yukio Takeshima, AMATYA VISHWA JEET, Mawas Amany Sayed, Kei Kushitani, Yukio Takeshima, The 56th Annual Meeting of the Japan Lung Cancer Society, 2015/11/26, Without Invitation, English, The 56th Annual Meeting of the Japan Lung Cancer Society, PACIFICO Yokohama, experimental
  36. BMET-28 ROLE OF NUCLEAR PTEN IN THE BRAIN METASTASES MECHANISM, Ryo Nosaka, Fumiyuki Yamasaki, Takeshi Takayasu, Vishwa Jeet Amatya, Yukio Takeshima, Kazuhiko Sugiyama, Kaoru Kurisu, 20th Annual Scientific Meeting of the Society for Neuro-Oncology, 2015/11/19, Without Invitation, English, Society for Neuro-Oncology, San Antonio, Texas, published
  37. MicroRNA profiling of mesothelioma cell lines & their biological function, AMATYA VISHWA JEET, Mawas Amany Sayed, Kei Kushitani, Yukio Takeshima, AMATYA VISHWA JEET, Mawas Amany Sayed, Kei Kushitani, Yukio Takeshima, 2015/10/31, Without Invitation, English, experimental
  38. Immunohistochemical study of multicentric glioma, 2015/05/29, Without Invitation, English, experimental
  39. Functional analysis of miR-214 transfection on mesothelioma cell lines, The 104th Annual Meeting of Japanese Society of Pathologists, 2015/04/30, Without Invitation, English, experimental
  40. Functional role of mir-1, mir-145, and mir-214 in mesothelioma cell proliferation and invasion, The 104th Annual Meeting of Japanese Society of Pathologists, 2015/04/30, Without Invitation, English, experimental
  41. MiRNA-182, -183 promotes cell growth, invasion, and suppresses apoptosis in mesothelioma cells, AMATYA VISHWA JEET、櫛谷　桂、武島幸男, The 55th Annual Meeting of the Japan Lung Cancer Society, 2014/11/14, Without Invitation, English, experimental
  42. microRNA profiling and its biological effect on mesothelioma cell lines., Amatya VISHWA JEET, Mawas Amany Sayed、相葉裕幸、櫛谷桂、武島幸男, 2014/10/11, Without Invitation, Japanese, experimental
  43. MiRNA-182, -183 promotes cell growth, invasion and suppressed apoptosis in mesothelioma cells, AMATYA VISHWA JEET, 2014/04/24, Without Invitation, English, experimental
  44. CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesotheliom, Aoe K, Amatya Vishwa Jeet, Fujimoto N, Ohnuma K, Hosono O, Hiraki A, Fujii M, Yamada T, Dang NH, Takeshima Y, Inai K, Kishimoto T and Morimoto C, The 11th International Conference of the International Mesothelioma Interest Group, 2012/09/11, Without Invitation, English, Boston, USA, published
  45. MicroRNA profiling of mesothelioma and mesothelioma-unrelated pleura using taqman array, 2012/04/26, Without Invitation, English, published
  46. CD9 expression in mesothelioma: A correlation with clinicopathological factors and survival of patients, AMATYA VISHWA JEET, Takeshima Y, Yamada T, Kushitani K, Morimoto C, Inai K, The 10th International Conference of the International Mesothelioma Interest Group, 2010/08/31, Without Invitation, Japanese
  47. Over expression of CD26/DPP4 in mesothelioma tissue and mesothelioma cell lines, AMATYA VISHWA JEET, Takeshima Y, Yamada T, Kushitani K, Morimoto C, Inai K, The 10th International Conference of the International Mesothelioma Interest Group, 2010/08/21, Without Invitation, Japanese
  48. Caveolin-1 is a novel immunohistochemical marker of malignant mesothelioma and differentiated epithelioid mesothelioma from lung adenocarcinoma, AMATYA VISHWA JEET, Takeshima Y, Kohno H, Kushitani K, Yamada T, Morimoto C. and Inai K., The 9th International Conference of the International Mesothelioma Interest Group Congress, 2008/09/25, Without Invitation, Japanese, Amsterdam, Netherlands, experimental
  49. Caveolin-1 is a novel immunohistochemical marker of malignant mesothelioma and differentiated epithelioid mesothelioma from lung adenocarcinoma, AMATYA VISHWA JEET, Takeshima Y, Kohno H, Kushitani K, Yamada T, Morimoto C and Inai K., The 9th International Conference of the International Mesothelioma Interest Group Congress, 2008/09/25, Without Invitation, Japanese, Amsterdam, Netherlands

External Funds

Acceptance Results of Competitive Funds

  1. KAKENHI, Comprehensive analysis of gene expression in malignant mesothelioma using Affymetrix GeneChip array, 2007, 2008
    Permalink

Social Activities

History as Peer Reviews of Academic Papers

  1. 2022, Frontiers in Oncology, Molecular and Cellular Oncology, Editor, Associate Editor, 2
  2. 2022, Case Reports in Pathology, Editor, Editorial Board Member
  3. 2022, Molecular Medicine Reports, Editor, Editorial Board Member
  4. 2022, Annals of Clinical Pathology, Editor, Editorial Board Member
  5. 2022, Internal Medicine Inside, Editor, Editorial Board Member